- Pendahuluan
- Farmakologi
- Formulasi
- Indikasi dan Dosis
- Efek Samping dan Interaksi Obat
- Penggunaan pada Kehamilan dan Ibu Menyusui
- Kontraindikasi dan Peringatan
- Pengawasan Klinis
Formulasi Daclatasvir
Daclatasvir tersedia dalam bentuk oral, yaitu tablet dengan kekuatan 30 mg, 60 mg, dan 90 mg.[4,9,13]
Bentuk Sediaan
Daclatasvir tersedia dalam bentuk tablet dengan kekuatan 30 mg, 60 mg, dan 90 mg.[4,9,13]
Referensi
2. Colombo MG, Musabayev EI, Ismailov UY, Zaytsev IA, Nersesov A V., Anastasiy IA, et al. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World Journal of Gastroenterology. 2019;25:3897–919. https://doi.org/10.3748/wjg.v25.i29.3897.
3. Chung RT, Ghany MG, Kim AY, Marks KM, Naggie S, Vargas HE, et al. Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating Hepatitis C Virus infection. Clinical Infectious Diseases. 2018;67:1477–92. https://doi.org/10.1093/cid/ciy585.
4. Association E. EASL Recommendations on Treatment of Hepatitis C 2016. Journal of Hepatology. 2017;66:153–94. https://doi.org/10.1016/j.jhep.2016.09.001.
5. Shah DACLATASVIR, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, et al. The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. CMAJ. 2018;190:E677–87. https://doi.org/10.1503/cmaj.170453.
9. Montgomery M, Ho N, Chung E, Marzella N. Daclatasvir (Daklinza). vol. 41. MediMedia, USA; 2016.
13. Multum C. Drugs. Daclatasvir 2019. https://daclatasvir.drugs.com/mtm/daclatasvir.html.
17. PIO Nas. Daclatasvir n.d. http://pionas.pom.go.id/cari/konten/daclatasvir.
18. Alavian SM, Rezaee-Zavareh MS. Daclatasvir-based Treatment Regimens for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis. Hepatitis Monthly. 2016;16:e41077. https://doi.org/10.5812/hepatmon.41077.
19. Ahmed OA, Safwat E, Khalifa MO, Elshafie AI, Fouad MHA, Salama MM, et al. Sofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a cohort of Egyptian patients: An experiment the size of egyptian village. International Journal of Hepatology. 2018;2018. https://doi.org/10.1155/2018/9616234.
20. Muir AJ, Poordad F, Lalezari J, Everson G, Dore GJ, Herring R, et al. Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis. JAMA - Journal of the American Medical Association. 2015;313:1736–44. https://doi.org/10.1001/jama.2015.3868.
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)